Vesilute 10mg

Disclaimer: This compound is not approved for human or veterinary use and must not be administered to any human or animal subject outside of a formally approved research protocol. Iron Mountain Labz supplies this compound strictly for in vitro and preclinical research use only. 

Overview of Vesilute

Vesilute (Glu-Asp) is a synthetic dipeptide bioregulator composed of two amino acids, glutamic acid and aspartic acid – sequenced as Glu-Asp. 

Vesilute is studied in preclinical settings for its proposed interactions with urogenital tissue at the cellular level. Research models indicate the Glu-Asp sequence may interact with chromatin structures in urinary bladder and prostate tissue, with proposed involvement in gene expression modulation and protein synthesis regulation.

All preclinical studies referenced in this document were conducted under institutional oversight consistent with IRB, IACUC, and AWA guidelines. Vesilute is supplied by Iron Mountain Labz exclusively for use under equivalent institutional research compliance frameworks. 

Section	Details
Molar Mass	262.22 g/mol
Chemical Formula	C₉H₁₄N₂O₇
Synonyms	H-Glu-Asp-OH; Glu-Asp; ED dipeptide; | alpha-glutamylaspartic acid; | L-α-Glutamyl-L-aspartic acid
Classification	Dipeptide Bioregulator / Khavinson Cytomedine
Ingredients / Composition	Vesilute (Glu-Asp) as the key component at 98%+ purity
Shelf Life	2 years
Storage Instructions	Store as lyophilized powder at –18 °C or below, protected from light and moisture
Regulatory Status	Research Use Only (RUO). Not approved by the FDA for use outside controlled laboratory settings.

 

Why Buy Vesilute 10mg from Iron Mountain Labz?

Researchers prefer Iron Mountain Labz for sourcing Vesilute 10mg for the following reasons:

• Vesilute at Iron Mountain Labz is tested via HPLC and confirmed at 99%+ purity.
• The assay result meets research-grade standards at 98%+ composition.
• A Certificate of Analysis (COA) is provided for independent verification of each batch.

Frequently Asked Questions

What is Vesilute, and what is it studied for in research? 

Vesilute is a synthetic dipeptide bioregulator (Glu-Asp) belonging to the Khavinson cytomedine peptide family. It is studied in preclinical research settings for its proposed role in urogenital tissue regulation, specifically regarding cellular function in the bladder and prostate gland. All research is conducted under laboratory conditions in research models only.

How does Vesilute work in research models? 

Preclinical data suggest Vesilute may interact with chromatin remodeling pathways in urogenital tissue. The Glu-Asp sequence is proposed to influence epigenetic mechanisms — specifically heterochromatin structure — which may modulate gene expression and protein synthesis in target tissue. Research also indicates potential involvement in neuromuscular signaling within the detrusor muscle of research models.

What are the observed effects of Vesilute in experimental settings? 

In preclinical models, Vesilute has been studied in the context of detrusor contractility normalization, urological smooth muscle regulation, and microcirculation within prostate tissue. Experimental animal studies have examined its capacity to modulate bladder function parameters under conditions of infravesical obstruction.

How should Vesilute be handled in a laboratory setting? 

Vesilute 10mg is supplied as a lyophilized powder and should be stored at –18 °C or below, away from light and moisture. Reconstitution should be performed using bacteriostatic water under sterile conditions. Researchers are advised to consult the Safety Data Sheet (SDS) prior to handling and to follow all applicable laboratory safety protocols, including the use of appropriate PPE. This compound is intended for use by qualified researchers in controlled laboratory environments only.

Is Vesilute approved for human consumption? 

Vesilute is not approved by the FDA or any other regulatory authority for human consumption or clinical use. It is classified as a research compound and is legally available for laboratory and investigational research purposes only. Iron Mountain Labz supplies Vesilute strictly for in vitro and preclinical research applications.

Vesilute 10mg is intended strictly for laboratory research purposes and is not approved for human consumption.

References

Khavinson, V. K., Popovich, I. G., Linkova, N. S., Mironova, E. S., & Ilina, A. R. (2021). Peptide Regulation of Gene Expression: A Systematic Review. Molecules, 26(22), 7053. https://pubmed.ncbi.nlm.nih.gov/34834147/

Khavinson, V. Kh., Solov’ev, A. Yu., Zhilinskiy, D. V., Shataeva, L. K., & Vaniushin, B. F. (2012). Epigenetic aspects of peptide regulation of aging. Advances in Gerontology, 25(1), 11–22. https://pubmed.ncbi.nlm.nih.gov/22708439/

Lezhava, T., Jokhadze, T., Monaselidze, J., Buadze, T., Gaiozishvili, M., Sigua, T., Khujadze, I., Gogidze, K., Mikaia, N., & Chigvinadze, N. (2023). Epigenetic Modification Under the Influence of Peptide Bioregulators on the “Old” Chromatin. Georgian Medical News, 335, 79–83. https://pubmed.ncbi.nlm.nih.gov/37042594/

Note: No PubMed-indexed studies specific to Vesilute (H-Glu-Asp-OH, CAS 3918-84-1) as a named compound were identified. All findings above are from preclinical research on the broader class of short ED-sequence bioregulator peptides. Results are not consistent across all experimental models, and data remain limited without compound-specific validation or human clinical evidence.